BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹4.36 Cr | ₹2.67 Cr | ₹2.69 Cr | ₹1.07 Cr | ₹2.50 Cr |
What is the latest Long Term Provisions ratio of BLISS GVS PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹4.36 Cr |
| Mar2024 | ₹2.67 Cr |
| Mar2023 | ₹2.69 Cr |
| Mar2022 | ₹1.07 Cr |
| Mar2021 | ₹2.50 Cr |
How is Long Term Provisions of BLISS GVS PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.36 Cr | 63.20 | |
| Mar2024 | ₹2.67 Cr | -0.56 | |
| Mar2023 | ₹2.69 Cr | 150.37 | |
| Mar2022 | ₹1.07 Cr | -57.01 | |
| Mar2021 | ₹2.50 Cr | - | |
Compare Long Term Provisions of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹2,961.9 Cr | 3% | 8.2% | 145.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,735.0 Cr | -0.6% | 10.3% | 4.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,312.0 Cr | 1.4% | 11% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,369.0 Cr | -1.5% | 3.3% | 37.6% | Stock Analytics | |
| CIPLA | ₹107,205.0 Cr | -2.6% | 7.9% | -13.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,592.0 Cr | -3.2% | 2.7% | 10.6% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 3% |
8.2% |
145.2% |
| SENSEX | -4.3% |
-2.6% |
-7.6% |
You may also like the below Video Courses